Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 3:14:1150036.
doi: 10.3389/fendo.2023.1150036. eCollection 2023.

Application of oral inorganic iodine in the treatment of Graves' disease

Affiliations
Review

Application of oral inorganic iodine in the treatment of Graves' disease

Yixuan Huang et al. Front Endocrinol (Lausanne). .

Abstract

Iodine is a crucial trace element for the human body and the basic raw material for the synthesis of thyroid hormones. Oral inorganic iodine includes dietary iodine and therapeutic iodine, both of which are closely associated with thyroid immunity and metabolism. Graves' disease (GD), also known as diffuse toxic goiter, is characterized by hyperthyroidism and high iodine metabolism. Clinically, patients diagnosed with GD are often asked to limit iodine intake or even avoid iodine in their diet. The latest research has demonstrated that the interference of dietary iodine with antithyroid drugs (ATDs) treatment may be overestimated. In addition, as a medication for GD treatment, the administration of inorganic iodine has shown positive results in patients with mild hyperthyroidism, a low thyroid autoantibody concentration, a small thyroid volume, a high iodine diet and so on. Inorganic iodine may also be used as an alternative when patients experience side effects with traditional ATDs and for those who still prefer conservative treatment. Due to its low teratogenicity, blood toxicity and bone marrow toxicity, inorganic iodine plays a unique role in special populations, such as pregnant or lactating patients and patients receiving tumor radiotherapy or chemotherapy. In this review, the research progress, biological function, doses and effects, applicable populations and specific applications of dietary iodine and therapeutic iodine are summarized to provide references for the diagnosis and treatment of GD, thus improving the quality of life of GD patients.

Keywords: Graves’ disease; diet; inorganic iodine; special population; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The mechanism of iodine in the thyroid gland. An intuitive view of the mechanism of normal and high iodine levels on the thyroid gland and thyroid hormone synthesis. The inhibition of high iodine levels on thyroid hormone synthesis (Wolff-Chaikoff effect) is shown in red. NIS, sodium iodide symporter; TPO, thyroid peroxidase; MIT, monoiodo-tyrosine; DIT, diiodo-tyrosine; T3, triiodothyronine; T4, thyroxine; PDS, anion exchanger pendrin; MCT8, monocarboxylate transporter 8.

Similar articles

Cited by

References

    1. Noh JY, Chino T, Ito K. Treatment with inorganic iodine for graves' hyperthyroidism. Nihon Rinsho (2006) 64(12):2269–73. - PubMed
    1. Zbigniew S. Iodine prophylaxis in the lights of the last recommendation of WHO on reduction of daily salt intake. Recent Pat Endocr Metab Immune Drug Discovery (2017) 11(1):39–42. doi: 10.2174/1872214811666170608120810 - DOI - PubMed
    1. Chai J, Zhang R, Zheng W, Zhang G, Jia Q, Tan J, et al. . Effect of lugol's solution on 131I therapy efficacy in graves' disease. Clin Exp Med (2022). doi: 10.1007/s10238-022-00859-4 - DOI - PubMed
    1. Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, et al. . Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab (2020) 34(1):101388. doi: 10.1016/j.beem.2020.101388 - DOI - PubMed
    1. Yoshihara A, Noh JY, Watanabe N, Kunii Y, Suzuki M, Matsumoto M, et al. . Characteristics of patients with graves' disease whose thyroid hormone levels increase after substituting potassium iodide for methimazole in the first trimester of pregnancy. Thyroid (2020) 30(3):451–6. doi: 10.1089/thy.2019.0392 - DOI - PubMed

Publication types

LinkOut - more resources